BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2680409)

  • 21. [Hypercalcemia of malignancy].
    Tomita A
    Rinsho Byori; 1989 Feb; 37(2):138-42. PubMed ID: 2733179
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physiopathology of malignant osteolysis].
    Delmas PD
    Pathol Biol (Paris); 1990 Oct; 38(8):855-6. PubMed ID: 2274388
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical practice. Hypercalcemia associated with cancer.
    Stewart AF
    N Engl J Med; 2005 Jan; 352(4):373-9. PubMed ID: 15673803
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypocalcemia in malignant diseases].
    Heidbreder E; Schafferhans K; Heidland A
    Klin Wochenschr; 1983 Aug; 61(16):773-83. PubMed ID: 6355639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 27. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
    Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
    Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenge of hypercalcemia in cancer.
    Poe CM; Radford AI
    Oncol Nurs Forum; 1985; 12(6):29-34. PubMed ID: 3851449
    [No Abstract]   [Full Text] [Related]  

  • 29. Sputum cytology: a valuable addition to the investigation of hypercalcemia.
    Reith PE; Freeman JB; Granner DK
    Am Surg; 1977 Aug; 43(8):538-9. PubMed ID: 889194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypercalcemia. II. Etiology. Infantile kinds].
    Henrard JC
    Presse Med (1893); 1971 Nov; 79(50):2285-90. PubMed ID: 5129869
    [No Abstract]   [Full Text] [Related]  

  • 31. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
    Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ
    N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302
    [No Abstract]   [Full Text] [Related]  

  • 32. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
    Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
    Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcemia of malignancy.
    Mundy GR; Guise TA
    Am J Med; 1997 Aug; 103(2):134-45. PubMed ID: 9274897
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium.
    Shevrin DH; Bressler LR; McGuire WP; Kukreja SC; Kukla LJ; Lad TE
    Clin Pharm; 1985; 4(2):204-5. PubMed ID: 2985326
    [No Abstract]   [Full Text] [Related]  

  • 35. [About the relations between dermatomyositis and malignant tumours].
    Holzmann H; Herz E
    Arztl Forsch; 1969 Oct; 23(10):335-48. PubMed ID: 4316689
    [No Abstract]   [Full Text] [Related]  

  • 36. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous cell carcinoma of the pancreas associated with hypercalcemia.
    Brayko CM; Doll DC
    Gastroenterology; 1982 Dec; 83(6):1297-9. PubMed ID: 7129033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcemia in malignancy.
    Bell B
    J Ky Med Assoc; 1980 May; 78(5):275-8. PubMed ID: 7373118
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue, weakness, anemia and hypercalcemia in a 63-year-old woman.
    Gelston A; Sheldon H
    Can Med Assoc J; 1981 Feb; 124(4):391-6. PubMed ID: 7214268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.